Article

Dr. Lindstrom takes on leadership of ASCRS Foundation

The American Society of Cataract and Refractive Surgery's (ASCRS) Executive Committee announced that Richard L. Lindstrom, MD, founding partner of Minnesota Eye Consultants, Minneapolis, will head the ASCRS Foundation.

Arlington, VA-The American Society of Cataract and Refractive Surgery’s (ASCRS) Executive Committee announced that Richard L. Lindstrom, MD, founding partner of Minnesota Eye Consultants, Minneapolis, will head the ASCRS Foundation.

Dr. Lindstrom’s predecessor is I. Howard Fine, MD, Eugene, OR, who was the first chairman of the foundation. Under Dr. Fine’s leadership, the foundation has grown to a $5 million organization with broad support, funding, and a substantial list of programs and achievements.

Dr. fine oversaw the foundation’s humanitarian program, which included the construction, outfitting, and operation of the Robert Sinskey Eye Institute in Addis Ababa, Ethiopia, a full-service medical and surgical eye-care facility with a staff of seven that treats more than 7,000 patients per year.

Dr. Lindstrom’s experience includes work with non-profits and foundation management, having led programs for the University of Minnesota, the Eye Bank Association of America, the Minnesota Lions Eye Bank, and the Phillips Eye Institute. He is a past-president of ASCRS and a renowned lecturer, teacher, consultant, and surgeon.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.